Enfusion Statistics

Share Statistics

Enfusion has 94.8M shares outstanding. The number of shares has increased by 1.71% in one year.

Shares Outstanding	94.8M
Shares Change (YoY)	1.71%
Shares Change (QoQ)	0%
Owned by Institutions (%)	99.99%
Shares Floating	46.32M
Failed to Deliver (FTD) Shares	256,308
FTD / Avg. Volume	21.86%

Short Selling Information

The latest short interest is 2.95M, so 0% of the outstanding shares have been sold short.

Short Interest	2.95M
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.64

Valuation Ratios

The PE ratio is 335.84 and the forward PE ratio is 29.08. Enfusion's PEG ratio is -4.14.

PE Ratio	335.84
Forward PE	29.08
PS Ratio	4.7
Forward PS	3.7
PB Ratio	12.95
P/FCF Ratio	30.54
PEG Ratio	-4.14

Financial Ratio History

Enterprise Valuation

Enfusion has an Enterprise Value (EV) of 1.27B.

EV / Sales	6.31
EV / EBITDA	206.65
EV / EBIT	36.67
EV / FCF	40.97

Financial Position

The company has a current ratio of 3.42, with a Debt / Equity ratio of 0.28.

Current Ratio	3.42
Quick Ratio	3.42
Debt / Equity	0.28
Debt / EBITDA	3.3
Debt / FCF	0.65
Interest Coverage	0

Financial Efficiency

Return on Equity is 3.86% and Return on Invested Capital is 1.93%.

Return on Equity	3.86%
Return on Assets	1.97%
Return on Invested Capital	1.93%
Revenue Per Employee	$176.39K
Profits Per Employee	$2.47K
Employee Count	1,143
Asset Turnover	1.41
Inventory Turnover	n/a

Taxes

Income Tax	4.57M
Effective Tax Rate	61.79%

Stock Price Statistics

The stock price has increased by 34.5% in the last 52 weeks. The beta is 0.93, so Enfusion's price volatility has been higher than the market average.

Beta	0.93
52-Week Price Change	34.5%
50-Day Moving Average	11.1
200-Day Moving Average	9.83
Relative Strength Index (RSI)	42.68
Average Volume (20 Days)	1,172,308

Income Statement

In the last 12 months, Enfusion had revenue of 201.61M and earned 2.82M in profits. Earnings per share was 0.02.

Revenue	201.61M
Gross Profit	136.74M
Operating Income	6.16M
Net Income	2.82M
EBITDA	6.16M
EBIT	6.16M
Earnings Per Share (EPS)	0.02

Full Income Statement

Balance Sheet

The company has 54.48M in cash and 20.31M in debt, giving a net cash position of 34.17M.

Cash & Cash Equivalents	54.48M
Total Debt	20.31M
Net Cash	34.17M
Retained Earnings	-170.11M
Total Assets	143.26M
Working Capital	66.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 34.68M and capital expenditures -3.63M, giving a free cash flow of 31.05M.

Operating Cash Flow	34.68M
Capital Expenditures	-3.63M
Free Cash Flow	31.05M
FCF Per Share	0.34

Full Cash Flow Statement

Margins

Gross margin is 67.82%, with operating and profit margins of 3.05% and 1.4%.

Gross Margin	67.82%
Operating Margin	3.05%
Pretax Margin	3.66%
Profit Margin	1.4%
EBITDA Margin	3.05%
EBIT Margin	3.05%
FCF Margin	15.4%

Dividends & Yields

ENFN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	0.3%
FCF Yield	3.27%

Dividend Details

Analyst Forecast

The average price target for ENFN is $12.25, which is 13.8% higher than the current price. The consensus rating is "Hold".

Price Target	$12.25
Price Target Difference	13.8%
Analyst Consensus	Hold
Analyst Count	3

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$0.09
Lynch Upside	-99.16%
Graham Number	0.74
Graham Upside	-93.12%

Scores

Altman Z-Score	14.44
Piotroski F-Score	5

Enfusion Inc. (ENFN)